CHE Xin-yu, LI Xue-yuan, TIAN Xiang-feng, ZHANG Peng
Objective To thoracic tumors in non-small cell lung cancer,for example,investigated the three-dimensional conformal radiation therapy (3DCRT) combined with Shenqi Fuzheng Injection treatment of non-small cell lung cancer (NSCLC) effectiveness.Methods To clinical NSCLC refused surgery or lose the timing of surgical operation in treating 83 patients were randomly assigned into control group and experimental group,and control group 41 cases,42 cases of the test group. For patients to take 3DCRT combined with Shenqi Fuzheng Injection,radiotherapy standards DT(60~70) Gy/(6~7) weeks,Shenqi Fuzheng Injection 250ml intravenous infusion dose per day. Prognostic Assessment two groups of patients,including short-term effect,gastrointestinal reactions,bone marrow suppression,and the incidence of radiation pneumonitis.Results all cases the remission rate was 53%,which controls the remission rate was 51.2%,the experimental group remission rate was 54.8%;P>0.05,Control group and experimental group there was no significant difference in the near future curative effect,the bone marrow suppression,gastrointestinal tract reaction,radioactive pneumonia complicated with rate control group were 3 cases 7.3%,5 cases 12.2%,9 cases 22% and 2 cases 4.8%,4 cases 9.5% and 7 cases 16.7%,treatment group was significantly lower than the control group,P<0.05,with statistical significance.Conclusion 3DCRT combined with Shenqi Fuzheng Injection effective treatment of NSCLC,significantly reduces radiation toxicity.